Because GCNT2 modifies polyLacNAcs, we hypothesized that GCNT2/I-branched glycans may control Gal-1- and/or Gal-3-binding in melanoma cells, thereby regulating downstream IGF1R and integrin-mediated signaling pathways. Here, IGF1R is linked to melanoma.